1.45 USD
▲+0.03+8.21%
盘后 1.35 +0.75%
2026-08-03
市值
$6.95M
市盈率
—
EPS
-2.63
股息率
—
52 周区间
0.84 – 2.68
成交量
149.39K
Beta
0.18
目标价
—
52W 低 0.8452W 高 2.68
价格走势
公司简介
Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer’s, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic ...